Cytodyn Inc (CYDY)

[misiu143]

2 days ago I sent an e-mail to Dr Chen in TaiMed asking him some questions about Ibalizumab. Just to finish with this subject...
Here his answer to me.

Dear Dr XXXXX

Thanks for interest in Ibalizumab project.

Ibalizumab is a monoclonal antibody that works by blocking HIV entry into the immune system cells ( CD4 + or T-cells ) the virus typically infects.
Ibalizumab is intended for use in combination with other anti-HIV drugs in people with multi - drug resistant HIV and limited treatment option.
This IV treatment phase III trial is ongoing. An easier and more convenient practice aims on label extension of IV dosing has being investigated in phase I/II .
Again Ibalizumab will be used in combination with HAART for treatment of HIV patient when approval.

A safety study of Ibalizumab given by subcutaneous injection in group at risk , HIV negative , healthy volunteers has completed phase I trial in 2012..

Please do not hesitate to contact me if you still have a question.

Best regards
Meng-Hsin Chen, Ph.D.
R&D VP, TaiMed Biologics